The Latest Breaking News from JNJ

As investors continue to digest the news of the recent bank collapses and the Federal Reserve’s quarter-percentage-point rate hike, the stock market outlook seems bumpy for some time. With speculations of an economic slowdown, investing in prominent large-cap stocks Johnson & Johnson (JNJ), Visa (V), and Merck & Co. (MRK)…

The worst banking crisis since 2008 could not stop the Fed from raising the benchmark interest rate. The possibility of further policy tightening and strict lending standards for banks might push the economy into a recession this year. Therefore, investing in large-cap pharma stocks Johnson & Johnson (JNJ), Merck &…

With the persistent rise in lifestyle diseases, the pharmaceutical industry is well poised for strong growth in the long term. Also, with the Fed likely to keep increasing the interest rates, the economy is likely to enter a recession, making pharma stocks attractive investment options. Therefore, investors could look to…

Tighter bank lending and the Fed’s continued fight against inflation will likely push the economy into a recession this year. In this scenario, investors can look to invest in the pharma giant Johnson & Johnson (JNJ), given its financial strength, reliable dividend payments, and solid growth prospects. Read more….

The recent financial turmoil from several bank failures, the Fed’s persistent hawkish stance to battle stubborn inflation, and renewed recession worries have kept the stock market highly volatile lately. Amid this backdrop, investors could consider buying fundamentally sound, large-cap stocks Taiwan Semiconductor (TSM), Johnson & Johnson (JNJ), and Merck (MRK),…

The recent bank failures have increased the likelihood of a recession, with many economists increasing the odds of an economic slump in the next 12 months. Amid this backdrop, investors could buy fundamentally strong stocks, Johnson & Johnson (JNJ) and Pfizer (PFE), which could help retire a millionaire. Read on.

Over the past year, the central bank has raised interest rates eight times to control inflation, which is still well above its 2% goal. The recent collapse of the financial system further complicates the Fed’s efforts in its fight against stubborn inflation. Amid this, it could be wise to invest…

Despite a drop in inflation, recent developments have been concerning. Moreover, the Fed is in a dilemma of stabilizing the banking industry or fighting inflation. With uncertainty looming over the stock market, high-quality blue-chip stocks Johnson & Johnson (JNJ), Coca-Cola (KO), and AbbVie (ABBV) could be solid additions to your…

The medical industry, which thrived during the pandemic years, is envisioned to remain buoyed despite the economic headwinds, thanks to the inelastic demand the sector faces. Against this backdrop, we think the strong fundamentals of Johnson and Johnson (JNJ) make it a wise portfolio addition. Read on….

The stock market will likely stay under pressure this year, with stubborn inflation and elevated interest rates. However, the Fed’s decision could largely be influenced by concerns about the recent banking crisis. Amid such uncertainty, fundamentally sound stocks Johnson & Johnson (JNJ), Abbott Laboratories (ABT), and Humana (HUM) could be…

The Silicon Valley Bank crisis will likely deter the Fed from raising interest rates by the expected 50 basis points next week. However, since the market is expected to remain highly volatile, it could be wise to invest in fundamentally strong stocks Johnson & Johnson (JNJ), Walmart (WMT), and General…